Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


J. Uriach & Cia SA

Division of Grupo Uriach

Latest From J. Uriach & Cia SA

Organon Reboots with Biotech

Organon's biologics R&D push relects similar moves by other mid-sized firms, and could help the company recover after a series of setbacks. But building biotech from discovery upwards will take time.
BioPharmaceutical Strategy

Europe's Flavors of Sustainable BioPharma

Europe's financing environment makes it difficult to build big biotech from scratch. But sustainable biopharma firms are nevertheless emerging--mostly through the transformation of existing pharma assets.
BioPharmaceutical Europe

Recent Dealmaking (11/2003)

Summarizing the month in European dealmaking.

Advanced In Vitro Cell Technologies SL

Advanced In Vitro Cell Technologies SL (Advancell) is Spain's first university biotechnology spin-out. Based at the Barcelona Science Park, the company is taking advantage of its head start and the new emphasis on R&D among Spain's mid-sized private pharmaceutical companies to create a market for its in vitro modelling capabilities.
BioPharmaceutical Europe
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Inflammation
  • Alias(es)
  • J. Uriach & Cia. SA
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Spain
  • Parent & Subsidiaries
  • Grupo Uriach
  • Senior Management
  • Enrique Uriach Tonello, Pres. & CEO
  • Contact Info
  • J. Uriach & Cia SA
    Phone: (34) 93 8649692
    Avinguda Camí Reial, 51-57
    Barcelona, 08184